|
What is PEG-INTRON/REBETOL®
(Ribavirin, USP) Capsules?
PEG-INTRON/REBETOL®
combination therapy is approved by the FDA for the treatment of chronic
hepatitis C in patients not previously treated with alpha interferons, who
have
compensated liver disease, and are at least 18 years of age.
It may be helpful for you to view our video "About Alpha
Interferons".
PEG-INTRON/REBETOL combination
therapy consists of two separate medications: PEG-INTRON®, which
is
injected and REBETOL®, which is taken orally.
What is
PEG-INTRON®?
PEG-INTRON® is a
"pegylated" or modified form of alpha interferon that works by
helping
boost the immune system to fight viruses-similar to how naturally
produced
interferon works in the human body.
It may be helpful for you to view our video "About Pegylated Alpha
Interferons".
What is REBETOL®?
REBETOL® is an antiviral drug (ie, a drug that fights
against viruses). REBETOL® alone is not effective for the treatment
of
chronic hepatitis C. REBETOL® is used in combination with
PEG-INTRON® to treat chronic
hepatitis
C.
Combination
Therapy for Highest Response Rates. The National Institutes
of
Health has recognized that the highest response rates in the treatment
of
chronic hepatitis C have been achieved through combination therapy with
ribavirin and pegylated alpha interferons.
PEG-INTRON/REBETOL combination
therapy is associated with some serious side effects and cannot be used
by
certain patients, including pregnant women and men whose partners are
pregnant.
REBETOL® should not be used alone to treat chronic
hepatitis C.
You can turn to The Be In Charge® Program for a vast
amount of additional information and support as you manage your hepatitis
C
treatment. Sign up now for this
tremendous support
tool.
|
Privacy Policy